Veramyst
These highlights do not include all the information needed to use VERAMYST safely and effectively. See full prescribing information for VERAMYST.VERAMYST (fluticasone furoate) Nasal SprayInitial U.S. Approval: 2007
Approved
Approval ID
8eaee9bf-91c7-484b-b8b1-b8242198181f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 1, 2010
Manufacturers
FDA
Physicians Total Care, Inc.
DUNS: 194123980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
fluticasone furoate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code54868-6168
Application NumberNDA022051
Product Classification
M
Marketing Category
C73594
G
Generic Name
fluticasone furoate
Product Specifications
Route of AdministrationNASAL
Effective DateSeptember 20, 2010
FDA Product Classification
INGREDIENTS (8)
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
ANHYDROUS DEXTROSEInactive
Code: 5SL0G7R0OK
Classification: IACT
FLUTICASONE FUROATEActive
Quantity: 27.5 ug in 1 1
Code: JS86977WNV
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUMInactive
Code: K679OBS311
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT